Difference between revisions of "Platelet-derived growth factor AB"
m |
m |
||
Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
− | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
Line 42: | Line 42: | ||
| Notes | | Notes | ||
|- | |- | ||
− | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:FXIIIa|*]] | [[Category:FXIIIa|*]] |
Latest revision as of 11:14, 10 March 2015
Platelet-derived growth factor AB | |
---|---|
Substrate peptide name | Platelet-derived growth factor AB |
Synonyms | PDGF.AB |
Determination type | In vitro |
Source | Homo sapiens |
Subcellular localization | Secreted |
Swissprot ID | P04085 |
Reactive glutamines | |
Reactive lysines | |
Substrate sequence | |
Structure | 3MJG |
Surface accessibility | |
Disorder prediction | |
Reference | PMID:23723146 |
Notes | |